 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Drewes G. on PAPER: Brunden KR. et al., 2010, The authors demonstrate clear beneficial effects of low concentrations of epothilone D, a... 15 Oct 2010.
|
|
|
 |
|
|
Drewes G. on PAPER: Bai Y. et al., 2008, This interesting and technically innovative paper addresses the still enigmatic physiological... 15 Feb 2008.
|
|
|
|
|
|
Drewes G. on PAPER: Bantscheff M. et al., 2007, Q&A with author. Questions by Gabrielle Strobel.
Q: What is the main thrust... 29 Aug 2007.
|
|
|
|
|
|
Drewes G. on NEWS: MARK Homologue Sparks Tau Terror in Fruit Fly, This paper describes an intriguing Drosophila model of tau phosphorylation causing tau... 8 Mar 2004.
|
|
|
|
|
|
Drewes G. on NEWS: BACE Goes Rafting after APP, Recommendation Only. 29 Sep 2003.
|
|
|
|
|
|
Drewes G. on NEWS: BACE Goes Rafting after APP, Despite the problems with chemical tractability, β-secretase (BACE) remains one of the most... 26 Sep 2003.
|
|
|
|
|
|
Drewes G. on PAPER: Crystal AS. et al., 2003, Pen2 is a 101-residue molecule with two predicted transmembrane domains. Topology models predict... 1 Apr 2003.
|
|
|
|
|
|
Drewes G. on NEWS: Homing in on Roles for PS Complex Proteins APH-1 and PEN-2, It has only been a few months that APH-1 and PEN-2 were discovered as major players in... 27 Jan 2003.
|
|
|
|
|
|
Drewes G. on NEWS: Clever Joining of Databases: New Way to Finger Disease Genes, Lander and colleagues combine data from genomics, transcriptomics, and proteomics, to find the... 14 Jan 2003.
|
|
|
|
|
|
Drewes G. on NEWS: Measuring Tyrosine Phosphorylation En Masse—Mass Spec Does the Trick, This study demonstrates the power of current state-of-the-art technology in "phosphoproteomics."... 10 Jan 2003.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our latest Webinar: 
